These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Liver function tests in a clinical comparison]. Stremmel W, Wojdat R, Groteguth R, Zoedler M, Ebener T, Niederau C, Becker H, Strohmeyer G. Z Gastroenterol; 1992 Nov; 30(11):784-90. PubMed ID: 1471385 [Abstract] [Full Text] [Related]
24. Relationship between 13C-aminopyrine breath test and the MELD score and its long-term prognostic use in patients with cirrhosis. Giannini EG, Savarino V. Dig Dis Sci; 2013 Oct; 58(10):3024-8. PubMed ID: 23817924 [Abstract] [Full Text] [Related]
26. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests. Forestier J, Dumortier J, Guillaud O, Ecochard M, Roman S, Boillot O, Lutringer D, Scoazec JY, Subtil F, Mion F. Eur J Gastroenterol Hepatol; 2010 May; 22(5):532-40. PubMed ID: 20164779 [Abstract] [Full Text] [Related]
28. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Zipprich A, Kuss O, Rogowski S, Kleber G, Lotterer E, Seufferlein T, Fleig WE, Dollinger MM. Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243 [Abstract] [Full Text] [Related]
34. The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass. Gross JB, Reichen J, Zeltner TB, Zimmermann A. Hepatology; 1987 Apr; 7(3):457-63. PubMed ID: 3570157 [Abstract] [Full Text] [Related]